In its judgment in Menarini and Others the Court clarified that Article 4(2) of Directive 89/105 must be interpreted as meaning that: Member States must, in all cases, provide for the possibility for an undertaking, which is concerned by a measure freezing or reducing the prices of all, or of certain categories of, medicinal products, of applying for a derogation from the price imposed pursuant to such measure [Joined Cases C-352/07 to C-356/07, C-365/07 to C-367/07 and C-400/07 Menarini and Others [2009] EU:C:2009:217, para. 58.].
87 6. ASSESSMENT › 6.2. Compatibility with the internal market, Decision_act (EU) 2015/1300
In forcesince 27 Mar 2015
Judgment of the Court (Fourth Chamber) of 2 April 2009. A. Menarini Industrie Farmaceutiche Riunite Srl and Others v Ministero della Salute Decision
2 Apr 2009 · 62007CJ0352